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Inflammatory caspases are essential effectors of
inflammation and cell death. Here, we investigated
their roles in colitis and colorectal cancer and report
a bimodal regulation of intestinal homeostasis, in-
flammation and tumorigenesis by caspases-1 and
12. Casp1/ mice exhibited defects in mucosal
tissue repair and succumbed rapidly after dextran
sulfate sodium administration. This phenotype was
rescued by administration of exogenous inter-
leukin-18 and was partially reproduced in mice defi-
cient in the inflammasome adaptor ASC. Casp12/
mice, in which the inflammasome is derepressed,
were resistant to acute colitis and showed signs of
enhanced repair. Together with their increased in-
flammatory response, the enhanced repair response
of Casp12/ mice rendered them more susceptible
to colorectal cancer induced by azoxymethane
(AOM)+DSS. Taken together, our results indicate
that the inflammatory caspases are critical in the
induction of inflammation in the gut after injury,
which is necessary for tissue repair andmaintenance
of immune tolerance.
INTRODUCTION
The innate immune system provides first-line defenses against
invading microbial organisms and endogenous danger signals
by activating pathways that mediate tissue repair, inflammation,
and microbial clearance. This is especially important in the intes-
tinal mucosa in which pattern recognition receptors (PRRs) func-
tion to protect against microbial intrusion while maintaining
epithelial barriers in the presence of commensal microorgan-
isms. The need to maintain tolerance to commensal bacteria,
which present a permanent threat of invasion after mechanicalor immunological breach, requires a robust innate immunity
network at intestinal mucosal surfaces. Bacterial sensing by
PRRs is increasingly recognized to be critical for intestinal
homeostasis and tissue repair after damage (Brown et al.,
2007; Rakoff-Nahoum et al., 2004). Experimental animal models
have demonstrated that depletion of the commensal microflora
or deletion of the Toll-like receptor (TLR)-interleukin-1 (IL-1)
and IL-18 receptor adaptor, MyD88, render animals highly
susceptible in response to wounding of the epithelium with either
irradiation or dextran sulfate sodium (DSS), a sulfated polysac-
charide known to be directly toxic to colonic epithelium (Kitajima
et al., 1999; Rakoff-Nahoum et al., 2004). In addition to TLRs,
nucleotide-binding oligomerization domain containing 2 (NOD2)
has been recently shown to be involved in controlling DSS-
induced pathology. Notably, administration of the NOD2 agonist
muramyl didpeptide (MDP) to mice was shown to confer protec-
tion from acute DSS-induced injury (Watanabe et al., 2008).
NOD2 stimulation leads to the activation of MAP kinase and
NF-kB signaling pathways, and the latter has been extensively
studied in the context of chemical injury and colitis (Nenci
et al., 2007). Together, these studies suggest that innate
immune signaling triggered by the commensal bacteria-TLR or
NOD-NF-kB axis is necessary for tissue homeostasis and
immune tolerance.
Although physiologic levels of inflammation are protective,
excessive inflammation is deleterious and is at the basis of
inflammatory bowel disease (IBD) and inflammation-promoted
colorectal cancer (CRC). CRC is a frequent form of malignancy
and a major cause of death in the Western hemisphere. It arises
spontaneously or as a result of chronic inflammation. IBD
including ulcerative colitis and Crohn’s disease are associated
with an elevated risk of CRC (Clevers, 2004). It is believed that
a break in tolerance to the commensal bacteria is at the basis
of IBD pathogenesis. When commensal bacteria breach the
intestinal epithelial barrier, they trigger a state of chronic inflam-
mation, which is believed to be directly responsible for the
neoplastic transformation of the overlying intestinal epithelium
(Balkwill and Mantovani, 2001; Clevers, 2004). Production of cy-
tokines together with that of matrix-degrading enzymes, growthImmunity 32, 367–378, March 26, 2010 ª2010 Elsevier Inc. 367
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The Inflammasome in Homeostasis and Tumorigenesisfactors, and reactive oxygen species promote tumorigenesis by
creating a microenvironment favoring intestinal epithelial cell
proliferation, cell survival, and invasiveness.
Although the role of the NF-kB signaling pathway in CRC has
been explored, the contribution of the inflammasome and the
inflammatory caspases to intestinal homeostasis, colitis, and
CRC is not clear. The search for the molecular mechanisms
required for the activation of the inflammatory caspases led to
the identification of the NOD-like family of molecules (nucleo-
tide-binding domain and leucine-rich repeat containing mole-
cules [NLRs]). NLRs are large cytosolic PRRs that, upon sensing
microbial or danger signals, assemble inflammasomes and acti-
vate inflammatory caspases (Mariathasan and Monack, 2007;
McIntire et al., 2009). Caspases-1, -4, -5, and -12 in humans,
and caspases-1, -11, and -12 in rodents, are termed ‘‘inflamma-
tory’’ on the basis of their ability to regulate the production of the
proinflammatory cytokines IL-1b and IL-18. Caspase-1, the main
effector inflammatory caspase, directly processes its cytokine
substrates from proforms into mature biologically active forms,
whereas caspase-12 is a repressor of the inflammasome and
a molecular ‘‘brake’’ on caspase-1 activity (Yeretssian et al.,
2008).
Accumulating evidence points to a critical role of the inflam-
masome and the inflammatory caspases in intestinal homeo-
stasis and colitis. A recent report has identified single-nucleotide
polymorphisms (SNPs) in a regulatory region downstream of the
human NLRP3 gene, which were found to be associated with
Crohn’s disease susceptibility in individuals of European
descent. SNPs in this region result in decreased NLRP3 expres-
sion and dampened IL-1 family cytokine production (Villani et al.,
2009). Of these cytokines, IL-18 is the most relevant as it has
been suggested to contribute to intestinal epithelial cell regener-
ation as well as to chronic inflammation in IBD. In response to
DSS-induced injury, IL-18 deficiency has been shown to result
in severe colitis (Pizarro et al., 1999; Sivakumar et al., 2002; Ta-
kagi et al., 2003). Paradoxically, excessive IL-1 and IL-18
production has also been linked to morbidity and mortality in
response to DSS colitis. It has been demonstrated that the au-
tophagy protein ATG16L1 (autophagy-related 16-like 1), which
is implicated in Crohn’s disease, negatively regulates the inflam-
masome and that mice that lack ATG16L1 in hematopoeitic cells
hyperproduce IL-1b and IL-18 and are susceptible to DSS colitis
(Saitoh et al., 2008). Thus, it appears that IL-18 exerts a dual role
in intestinal homeostasis and colitis. Early in the mucosal
immune response, its expression by IECs and lamina propria
mononuclear cells is suggested to mediate a cytoprotective
role, but under chronic inflammation its excessive production
results in deleterious effects (Reuter and Pizarro, 2004).
In this report, we describe a role for the caspase-1 inflamma-
some in epithelial cell regeneration and tissue repair after injury.
We show that caspase-1-deficient mice were extremely suscep-
tible to DSS-induced injury succumbing very early on compared
to wild-type animals. This phenotype was primarily ascribed to
lack of IL-18 production by Casp1/ mice, given that it was
completely reversed by exogenous administration of this cyto-
kine. Moreover, we show that regulation of caspase-1 function
by caspase-12 was necessary for immune tolerance in the gut.
Casp12/ mice, in which the inflammasome is derepressed,
were resistant to acute and chronic colitis and showed signs of368 Immunity 32, 367–378, March 26, 2010 ª2010 Elsevier Inc.exaggerated epithelial cell compensatory proliferation. Together
with their increased inflammatory response, the enhanced repair
response ofCasp12/ mice rendered them more susceptible to
colorectal cancer induced by azoxymethane (AOM)+DSS. Alto-
gether, our results indicate that the inflammatory caspases are
critical regulators of intestinal homeostasis and that deregulation
of the caspase-1-caspase-12 axis of inflammation leads to
severe colitis and colitis-associated CRC.
RESULTS
Caspase-1 Is Required for Tissue Repair
in DSS-Induced Injury
Bacterial recognition by TLRs and Nod proteins and subsequent
signaling through the NF-kB pathway have been reported to be
important in maintaining intestinal epithelial tissue integrity (Rak-
off-Nahoum et al., 2004; Watanabe et al., 2008). To investigate
the role of the inflammatory caspases and the inflammasome
in intestinal homeostasis, we subjected wild-type (WT),
Casp1/, Casp12/, and Asc/ mice to an experimental
model of tissue injury and colitis. We hypothesized that the in-
flammasome and caspase-1 activity contributed to inflammation
during colitis and that Casp1/ mice would be protected from
colitis. To assess their response, we administered dextran
sulfate sodium (DSS) to mice in their drinking water for 5 days
and then allowed the animals to recover with clean drinking
water for an additional 4 days. Contrary to our hypothesis,
Casp1/ mice were extremely susceptible to this treatment
and began to die on day 5 after DSS. By day 9 all of the
Casp1/ mice had died (Figure 1A). In sharp contrast, all WT,
Asc/, and Casp12/ mice survived over this time course
(Figure 1A and data not shown). The body weight of Casp1/
mice steadily decreased and by day 8, Casp1/ mice had lost
more than 20% of their initial body weight (Figure 1B). In contrast
and similar to WT mice, the body weight of Casp12/ mice re-
mained constant throughout the experiment, whereas Asc/
mice had an intermediate phenotype and lost 10% of their
body weight by day 8 (Figure 1B). Casp1/ mice developed
severe diarrhea and rectal bleeding starting on day 5
(Figure 1C) and showed severe signs of colitis including drastic
shortening of the colon length at necropsy (Figure 1D and
Figure S1A available online).
Mice of all genotypes displayed epithelial erosion on day 5
(Figure S1B). However, Casp1/ mice displayed more severe
signs of injury (Figures 2A–2D and Figures S1B and S1C). By
day 8, WT and Casp12/ mice exhibited regeneration of the
intestinal epithelium (Figures 2A–2C), whereas Asc/ mice
had some remaining erosions, but unlike Casp1/ mice,
showed signs of re-epithelialization (Figures 2A–2C and Fig-
ure S1C). In contrast, Casp1/ mice showed no improvement
from day 5 to day 8, and few if any crypts were found throughout
their distal colons on day 8 (Figures 2A–2D). Labeling of epithelial
cell tight junctions by claudin-3 staining revealed normal expres-
sion and localization. In contrast, a defect in intestinal epithelial
restitution was evident in Casp1/ mice (Figure 2C and
Figure S1C). This was consistent with reduced intestinal epithe-
lial cell proliferation as revealed by proliferating cell nuclear
antigen (PCNA) staining (Figure 2B). Quantification of PCNA-
positive cells per 50-well-oriented crypts evaluated/mouse
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Figure 1. Casp1/ Mice Are Highly Susceptible to
Acute Dextran Sulfate Sodium Treatment
(A) WT and Casp1/ mice were given 3% DSS in their
drinking water for 5 days, then given regular drinking water
for an additional 3 days (days 6–8). Difference in survival
was determined with Kaplan-Meier analysis. This experi-
ment was repeated twice with similar results. In each
experiment, a group of five to seven mice was used per
genotype.
(B) Body weight loss of WT, Casp1/, Asc/ and
Casp12/ mice treated with DSS as in (A) and weighed
daily. Data represent the mean ± SEM of n = 8 mice/geno-
type. p values were calculated with ANOVA; **p < 0.01, ***p
< 0.001.
(C) Stool consistency and intestinal bleeding were moni-
tored on daily basis and diarrhea was scored for each
mouse. Diarrhea was graded on a scale of 0–4 as
described in the Experimental Procedures. Data represent
the means ± SEM. p values were calculated with ANOVA;
*p < 0.05, **p < 0.01.
(D) Colon length of DSS-treated mice was measured on
days 1, 5, and 8 after the start of DSS treatment. Data
represent the means ± SEM. p values were calculated
with ANOVA; **p < 0.01.
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from the top to the bottom of the crypt) indicated that whereas
Casp1/ mice had impaired IEC proliferation, Casp12/ mice
showed signs of exaggerated tissue repair (Figure 2E) with
hyperplastic crypts (Figures 2A–2D) and improved restitution
(Figure S1C). Interestingly, unlike Casp1/ mice, Asc/ mice
did not have impairment in these processes (Figures 2A–2C
and Figure S1B). To confirm the histopathological observations,
we examined epithelial tissue disruption and permeability by
a quantitative measurement, feeding mice on day 8 with FITC-
dextran and quantifying fluorescence in the serum 4 hr after
gavage. Figure 2F shows a significant increase of plasma FITC
fluorescence in Casp1/ mice compared to WT mice. Asc/
mice had a trend toward increased fluorescence; however, their
difference from WT mice was not significant (Figure 2F). These
results indicated that the caspase-1 inflammasome is required
to induce intestinal epithelial cell regeneration and tissue repair
after injury and that the milder phenotype of Asc/ mice could
be ascribed to its dual function in activating the inflammasome
while inhibiting the NF-kB pathway (Mariathasan et al., 2004;
Stehlik et al., 2002).
Increased Inflammation and NF-kB Activation
in the Colon of DSS-Treated Casp1/ Mice
To assess the severity and involvement of inflammation in the
colons of DSS-treated animals, we stained colon tissue sections
for neutrophil (Gr-1), macrophage (F4/80), and T lymphocyte
(CD4) infiltration. On day 5 after DSS treatment, there was no
evident difference in leukocyte infiltration among the genotypes
(Figures 3A–3C), despite the marked difference in morbidity and
mortality (Figure 1). On day 8, colon sections from Casp1/
mice displayed a drastic increase in Gr-1, F4/80, and CD4-posi-
tive cell numbers compared to those of all other genotypes understudy (Figures 3A–3C). Significant inflammation was evident in
75%–100% of the colon of Casp1/ mice, whereas its involve-
ment was less than 25% of the colon of WT animals and between
26%–50% in Asc/ mice (Figure 3D). Consistently, the acute
phase protein serum amyloid A (SAA), a marker of colitis, was
released at highest concentrations in the serum of Casp1/
mice on day 5 of the treatment, compared to WT and Asc/
mice (Figure 3E). On day 8, the titers of SAA in the serum were
saturating, masking differences among genotypes.
We next examined activation of the NF-kB pathway in the
colons of DSS-treated mice. Figure 3F depicts an immunoblot
of total colonic lysates that shows a robust induction of the
NF-kB-target gene IkBa in lysates of Casp1/ mice compared
to those of WT orCasp12/ mice.Asc/ mice had intermediate
amounts of IkBa. The induction of IkBa correlated well with the
severity of tissue damage and inflammation observed in the
different mouse genotypes and suggested that the amplified
inflammatory response in the colon of Casp1/ mice was
partially attributable to increased NF-kB activation. To determine
whether the enhanced inflammatory response in lesioned tissue
of Casp1/ mice was due to impaired host defense in these
mice, we used fluorescent in situ hybridization (FISH) staining
to label colon sections for the presence of commensal bacteria.
Our results indicated that caspase-1 deficiency not only abro-
gated the tissue repair response but also resulted in a defect in
controlling commensal bacterial invasion: labeled bacteria
were frequently observed in the lamina propria of colon sections
derived from Casp1/ mice but to a much lesser extent in those
of WT, Asc/, or Casp12/ mice at lesioned sites (Figure 3G).
Consistently, quantification of bacterial content in the colons,
mesenteric lymph nodes, and spleens of DSS-treated mice by
16S rRNA qPCR revealed enhanced bacterial invasion in tissues
derived from Casp1/ mice compared to WT mice (Figure 3H).Immunity 32, 367–378, March 26, 2010 ª2010 Elsevier Inc. 369
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Figure 2. Casp1/ Mice Have Impaired Epithelial Cell Regeneration and Tissue Repair after DSS Injury
(A) Hematoxylin and eosin (H&E) staining of colon sections derived from WT, Casp1/, Asc/, and Casp12/ mice on days 0 and 8 after the start of DSS treat-
ment (magnification 1003).
(B and C) Immunofluorescence was performed on colon sections derived from WT, Casp1/, Asc/, and Casp12/ mice on days 0 and 8 for examination of
proliferating cells (PCNA) (B) and tight junction (Claudin-3) (C); (magnification 1003).
(D) Histopathology scores evaluating the tissue involvement of crypt damage in WT, Casp1/, and Asc/ mice on days 5 and 8 after the start of DSS treatment.
Results represent means ± SEM. Student’s t test was performed for comparison of scores of Casp1/ or Asc/ mice to those of WT mice; *p < 0.05.
(E) Quantification of the numbers of PCNA+ cells shown in (B). On average, 50-well-oriented crypts were scored/mouse; ‘‘well-oriented’’ was defined as the crypt
lumen being present from top to bottom of the crypt.
(F) Plasma FITC-dextran concentrations on day 8 in WT,Casp1/, and Asc/ mice, 4 hr after oral gavage of FITC-dextran (400 mg/g of body weight), are shown.
Results represent means ± SEM. Student’s t test was used for statistical analysis. *p < 0.05; ns, nonsignificant.
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The Inflammasome in Homeostasis and TumorigenesisAltogether, our results suggest that during chemical-induced
injury, caspase-1 plays a role in limiting mucosal damage by
promoting regeneration of crypts and surface epithelia, thereby
blocking excessive stimulation of lamina propria immune cells
by luminal bacteria and inhibiting the production of chemotactic
factors. Moreover, caspase-1 is required to control the numbers
of commensal bacteria that leak into sites of colonic injury. These
two caspase-1 dependent functions may be key in hindering the
vicious cycle of inflammation caused by unregulated interactions
between host tissues and the luminal microbiota.
IL-18 Production by Intestinal Epithelial Cells
Is Critical for the Induction of Tissue Repair
To investigate the molecular basis of the impaired epithelial
regeneration in caspase-1-deficient mice, we first quantified370 Immunity 32, 367–378, March 26, 2010 ª2010 Elsevier Inc.the concentrations of IL-1b and IL-18 in the serum of DSS-
treated animals at different time points throughout the experi-
ment. Interestingly, IL-1b concentrations in the serum increased
minimally after DSS treatment (data not shown). In contrast,
IL-18 production was highly induced in the sera of WT mice on
days 5 and 8 after DSS treatment (Figure 4A). IL-18 is a key cyto-
kine produced in a caspase-1-dependent manner; thus not
surprisingly very little IL-18 was detected in the sera of
Casp1/ mice. In contrast, Asc/ mice, which displayed an
intermediate amount of DSS-induced colon tissue damage,
had little production of IL-18 on day 5 but regained IL-18 produc-
tion by day 8 (Figure 4A). It has been previously shown that IL-18
is essential for the early phase of wound healing, both in cuta-
neous wound models as well as in response to DSS (Ka¨mpfer
et al., 1999; Takagi et al., 2003). Moreover, both Il18/ and
Immunity
The Inflammasome in Homeostasis and TumorigenesisIL-18 receptor-deficient mice are susceptible to DSS colitis,
developing a severe disease associated with high mortality
and histopathological abnormalities similar to that in Casp1/
mice (Takagi et al., 2003). The induction of IL-18 in WT mice,
but not in Casp1/ mice, on days 5 and 8 after DSS treatment
suggested that IL-18 might mediate the caspase-1-dependent
tissue repair response after injury. To test this hypothesis, we
examined the effect of exogenous administration of recombi-
nant IL-18 (rIL-18) on the phenotype of Casp1/ mice in
response to acute DSS treatment. We injected Casp1/
mice with 0.05 mg rIL-18 or PBS daily on days 0, 1, and 2
post-DSS. Interestingly, this regimen completely reversed the
Casp1/ mice susceptibility phenotype given that 100% of
the rIL-18-injected Casp1/ animals survived the DSS treat-
ment and maintained a stable body weight compared to
PBS-treated Casp1/ controls (Figure 4B). The cytoprotective
effect of rIL-18 was evident when examining colon lengths at
necropsy (Figure S2A), quantifying bacterial invasion in the
colon with 16S rRNA qPCR (Figure 4C) as well as histologically
(Figure 4D).
Previous studies investigating the role of MyD88 in tissue
repair after DSS administration indicated an important contri-
bution of myeloid cells to this response (Pull et al., 2005; Rak-
off-Nahoum et al., 2004). To explore the role of myeloid cells in
IL-18 production and stimulation of epithelial regeneration, we
performed adoptive transfer of the myeloid compartment
from WT mice into Casp1/ mice during the course of DSS
treatment. This treatment did not improve the Casp1/ mice
survival rate or body weight loss (data not shown). A slight
amelioration was seen macroscopically, given that Casp1/
mice that received the adoptive transfer had longer colons at
necropsy compared to Casp1/ control mice (Figure S2B).
Histologically, although the colon tissue sections of Casp1/
mice with adoptive transfer had residual crypts left as
compared to Casp1/ mice (Figure 4E), the colon was highly
damaged as compared to colons from Casp1/ mice
treated with rIL-18 (Figure 4D). To further investigate the cell
population involved in the production of IL-18, we isolated
and purified IECs and different lamina propria cell populations
(macrophages, dendritic cells [DCs], and lymphocytes) from
untreated and colitic colons at different time points after injury
and quantified IL-18 secretion by ELISA. IECs seem to be the
primary source of IL-18 production after the DSS injury
(Figure 4F). This is consistent with the lack of rescue by adop-
tive transfer of myeloid cells (Figure 4E) and with previous
studies reporting IL-18 expression and localization predomi-
nantly to IECs of colons from Crohn’s disease patients (Pizarro
et al., 1999).
Caspase-12 Deficiency Enhances the Promotion
of Colitis-Associated CRC
Caspase-12 is a dominant-negative regulator of the caspase-1
inflammasome and NOD-NF-kB pathways (Saleh et al., 2004;
Saleh et al., 2006; LeBlanc et al., 2008). Although Casp12/
mice reacted similarly to WT mice when allowed to recover
from an acute DSS-induced injury (Figure 1) and exhibited
signs of improved repair (Figure 2), they had an increased
inflammatory response compared to WT animals (Figures 5A
and 5B). Immunoblot analysis of colonic lysates on days 5and 8 after DSS treatment revealed enhanced induction of
multiple NF-kB target genes, including those that encode
COX2, Bcl-xl, and cyclin D1 in the colons of Casp12/ mice
compared to those of WT animals (Figure 5A). Furthermore,
colons of DSS-treated Casp12/ mice hyperproduced proin-
flammatory cytokines and chemokines, such as IL-1b and KC
(Figure 5B). It is now well recognized that physiological inflam-
mation is beneficial in the intestine, whereas exaggerated
production of inflammatory mediators contributes to colitis
pathology. We therefore hypothesized that whereas the inflam-
matory response of Casp12/ mice rendered them resistant
to acute DSS treatment, hyperactivation of this response
would lead to susceptibility in response to sustained treatment
with DSS. Consistent with our hypothesis, Casp12/ mice
were highly susceptible to sustained DSS with less than 20%
of the mice surviving by day 15 after DSS treatment as
compared to 80% survival for WT mice (Figure S3). These
data indicated that the hyperinflammatory state induced by
the absence of the negative dominant role of caspase-12 on
inflammation was deleterious, leading to severe colitis. We
next subjected the Casp12/ mice to an established model
of chronic colitis induced by three cycles of low concentrations
of DSS separated by a break week of clean drinking water (Fig-
ure 5C). In contrast to the sustained treatment, the chronic
DSS regimen allows for epithelial regeneration and tissue
repair during the break weeks and is a more representative
model of chronic colitis. Consistent with their response to
acute DSS treatment and their enhanced tissue repair pheno-
type, Casp12/ mice were more resistant to chronic colitis
compared to WT animals, gaining weight by the end of the
experiment as compared to WT mice that lost 5% of their initial
body weight (Figure 5C).
Because chronic inflammation is linked to tumorigenesis, we
next sought to determine the contribution of the inflammatory
caspases to colitis-associated CRC. We therefore subjected
Casp12/ mice to an AOM+DSS regimen. AOM or azoxyme-
thane is a procarcinogen, which upon metabolic activation
in the liver and the distal colon induces the formation of
O6-methyl-guanine (Pegg, 1984). Both WT and Casp12/
mice survived the treatment and had similar body weights
throughout the experiment, with the Casp12/ mice gaining
weight by the end of the experiment as compared to WT mice
(Figure 5D), a result consistent with that obtained in the chronic
DSS experiments (Figure 5C). Strikingly, Casp12/ mice had a
much higher tumor burden than WT mice (Figure 5E). As ex-
pected, AOM induced tumors at the distal end of the colon in
WT mice (Figure 5E). Casp12/ mice, in contrast, had tumors
distributed from the distal end to the medial part of the colon,
thereby demonstrating increased tumorigenesis (Figure 5E).
Casp12/ mice had 17 tumors on average, whereas WT mice
had six (Figure 5G). The higher tumor burden was also high-
lighted by the weights of the colons, which were heavier in
Casp12/ mice compared to WT mice (Figure 5F). In addition
to the increase in tumor number, Casp12/ mice had larger
tumors, with more than 50% of the tumors being larger than
2 mm in diameter compared to 30% for WT mice (Figure 5H).
Taken together, these results suggested that the inflammatory
microenvironment created by Casp12 deficiency enhanced
tumor promotion and progression.Immunity 32, 367–378, March 26, 2010 ª2010 Elsevier Inc. 371
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Figure 3. Enhanced Inflammation and NF-kB activation in DSS-Treated Casp1/ Mice
(A–C) Immunofluorescence was performed on colon sections derived from WT, Casp1/, Asc/ and Casp12/ mice on days 0, 5, and 8 for examination of
neutrophil (Gr-1+ cells) (A), macrophage (F4/80+ cells) (B) and T lymphocyte (CD4+ cells) (C) infiltration; (magnification 1003).
(D) histopathology scores evaluating the tissue involvement of inflammation in WT, Casp1/, and Asc/ mice on days 5 and 8 after the start of DSS treatment.
Results represent means ± SEM. Student’s t test was performed for comparison of scores of Casp1/ or Asc/ mice to those of WT mice. *p < 0.05.
(E) Serum amyloid A (SAA) concentrations in the serum of mice on days 0, 1, 5, and 8 after DSS treatment were determined by ELISA. Data represent the
mean ± SEM. *p < 0.05.
(F) Total protein lysates, prepared from colon tissues of WT, Casp1/ Asc/, and Casp12/ mice on days 0 and 8 after DSS treatment, were analyzed for the
induction of IkBa expression by western blotting. b-actin was used to control for equal loading.
(G) Invasion of commensal bacteria was assessed by labeling bacteria in colon sections of WT, Casp1/, Asc/, and Casp12/ mice on days 5 and 8 after the
start of DSS treatment with fluorescence in situ hybridization (FISH); 2003 original magnification is shown. Tissues fromCasp1/ mice had the highest number of
invading commensal bacteria in the lamina propria. Insets (corresponding to white boxes) are magnified 4003 and show the presence of bacteria inside the
cytosol of host cells (white arrow).
(H) RNA from colon, mesenteric lymph node (MLN), and spleen was isolated and bacterial content was measured by quantitative real-time PCR of 16S rRNA.
Data represent means ± SEM of fold induction over untreated mice for each genotype (n = 4–7/genotype).
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Figure 4. Exogenous IL-18 Administration Rescues Casp1/ Mice from DSS-Induced Colitis
(A) IL-18 production in the serum of mice was determined by ELISA. Data represent the mean ± SEM. Student’s t test was used for statistical analysis. *p < 0.05,
**p < 0.01, ***p < 0.001; ns, nonsignificant.
(B) Casp1/ mice were injected on days 0, 1, and 2 with either PBS or 0.05 mg recombinant IL-18 (rIL-18) and given 3% DSS as in Figure 1A. Body weight loss of
mice treated with DSS and weighed daily is shown. Data represent the mean ± SEM (n = 4). Student’s t test was used for statistical analysis; *p < 0.05, **p < 0.01.
(C) Quantitative real-time PCR of 16S rRNA in the colon. Data represent the means ± SEM. Student’s t test was performed for statistical analysis. *p < 0.05, **p <
0.01.
(D) Hematoxylin and eosin (H&E) staining of colon sections derived from Casp1/ mice treated with PBS or rIL-18 on day 9 post-DSS; (magnification 1003).
(E) Hematoxylin and eosin (H&E) staining of colon sections derived from Casp1/ mice receiving PBS or adoptively transferred myeloid cells on day 9 after DSS;
(magnification 1003).
(F) Quantification of ex vivo production of IL-18 by purified IECs and sorted lamina propria cells from untreated and DSS-treated colons. Data represent the mean
± SEM. Student’s t test was used for statistical analysis. *p < 0.05, ***p < 0.001; ns, nonsignificant. IEC, intestinal epithelial cells; Lp, Lamina propria; Mac; macro-
phages; Dc, dendritic cells; and Others, all cells in Lp excluding macrophages and DCs that were purified by positive selection (see Experimental Procedures).
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Figure 5. Enhanced Tumorigenesis in Casp12/ Mice
(A) Immunoblot analysis of COX-2, Bcl-xl, cyclin D1, and IkBa in extracts of colon tissues derived from Casp12/ mice as compared to WT mice on days 5 and
day 8. b-actin was used to control for equal loading.
(B) RNA from the colons of WT and Casp12/ mice was isolated at the same time points as in (A) and analyzed for KC and IL-1b expression by quantitative real-
time PCR. Data represent means ± SEM of fold induction over untreated levels for each genotype (n = 3 per group). Student’s t test was used for statistical anal-
ysis. *p < 0.05.
(C) Body weight curves of WT and Casp12/ mice in a chronic model of DSS-induced colitis. Two percent DSS was given in the drinking water for three cycles of
5 days (black boxes) separated by 5 days of regular water. Mice were sacrificed on day 45.
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Figure 6. Caspase-12 Deficiency Increases
Cell Survival and Proliferation
(A) H&E and immunofluorescence staining of the
antiapoptotic protein Bcl-xl and proliferation
marker Ki67 from colon tissue sections containing
adenomas from WT and Casp12/ mice.
(B) Immunofluorescence staining of macrophage
infiltration with F4/80 antibodies.
(C) RNA was extracted from tumors derived from
WT or Casp12/ mice subjected to AOM+DSS
after the third cycle of DSS. The expression of IL-
6, MCP-1 and TNFa was examined by quantitative
real-time PCR. Data represent means ± SEM of
fold induction over untreated levels for each geno-
type (n = 7 per group). Student’s t test was used for
statistical analysis. *p < 0.05, **p < 0.01, ***p <
0.001.
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in Casp12/ Mice
The colon histology of the AOM+DSS-treated mice was exam-
ined so that the effects of caspase-12 deficiency on intestinal
homeostasis could be determined. Different types of adenocar-
cinomas had developed in WT and Casp12/ mice including
broad-based and pedunculated tumors (Figure 6A). However,
the increased number and size of tumors in Casp12/ mice
compared to those in WT mice suggested that caspase-12 defi-
ciency impacted on cell death, cell proliferation, or both.
Because of the increased expression of Bcl-xl in the colon of
Casp12/ mice in response to DSS-induced colitis (Figure 5A),
we investigated its expression pattern by immunohistochemistry
in the AOM+DSS-induced tumors. Colon sections from(D) Body weight curves of WT andCasp12/ mice in an AOM+DSS model of colitis-associated CRC. After a s
on day 0 (black arrow), 2% DSS was given in the drinking water for 3 cycles of 5 days (black boxes) separated b
day 123.
(E) Macroscopic view of the AOM+DSS-derived tumors in WT and Casp12/ mice. Representative results
(F) Colons of WT and Casp12/ mice were dissected, washed with PBS for removal of fecal content, cut lo
(G) Tumor incidence induced by AOM+DSS in WT and Casp12/ mice. Statistical analysis was performed wit
was repeated twice with similar results. In each experiment, a group of seven to ten mice was used per gen
(H) Size distribution of colonic tumors of WT and Casp12/ mice. More than 50% of the tumors of Casp
compared to 30% of the WT mice tumors.
Immunity 32, 367–37Casp12/ mice had a marked increase
in Bcl-xl staining in intestinal epithelial
cells, compared to colon sections derived
from WT mice (Figure 6A). This result indi-
cated that the enhanced tumorigenesis in
Casp12/ mice might be mediated by
enhanced survival of intestinal epithelial
cells partially through overexpression of
the antiapoptotic gene Bcl-xl. In addition
to its effects on cell survival, caspase-
12-deficiency stimulated cell proliferation
as revealed by increased Ki67 staining in
tumors of Casp12/ mice compared to
WT tumors (Figure 6A). The enhanced
proliferation and survival of the
Casp12/ intestinal epithelial cells is
associated with increased inflammationin the colons of these mice compared to WT mice. Indeed,
Casp12/ colon tissue sections collected after the third cycle
of DSS were studded with macrophages (F4/80+ cells)
compared to sections from WT mice (Figure 6B) and had
increased expression of the proinflammatory cytokines IL-6
and TNFa and the chemokine MCP-1 (Figure 6C). Altogether,
these data suggested that Casp12/ mice have an increased
ability to recruit macrophages, which leads to increased produc-
tion of inflammatory and tissue repair factors. Chronic activation
of these pathways leads to enhanced cell proliferation, cell
survival, and tumorigenesis. This result was corroborated by
a genomic analysis of colitis-associated tumorigenesis in WT
and caspase-12-deficient mice (Figure S4). A DNA microarray
experiment with normal and tumor RNA from WT andingle injection of azoxymethane ([AOM] 12.5 mg/kg)
y 2 weeks of regular water. Mice were sacrificed on
from three independent animals are shown.
ngitudinally, and weighed.
h the Student’s t test. ***p < 0.001. This experiment
otype.
12/ mice were larger than 1 mm in diameter as
8, March 26, 2010 ª2010 Elsevier Inc. 375
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expression across these samples and showed a significant
enrichment of genes mainly related to inflammation and immu-
nity in the Casp12/ mice tumors (Figures S4A and S4B). These
included Il1b, Il11, ccl7 (chemokine [C-C motif] ligand 7). and
tnfaip2 (TNFa-induced protein 2) (Figure S4C). Furthermore,
the tumor gene set of Casp12/ mice included genes involved
in proliferation, angiogenesis, and metastasis, such as the tran-
scription factor ELK3, which is regulated by the Ras/MAPK
signaling pathway, Icam1 (Intercellular adhesion molecule 1),
CD44 metastasis suppressor, and col4a1 [collagen a1(IV)] cell-
matrix interaction molecule. Interestingly, relative gene expres-
sion of Blm (Bloom Syndrome gene), which is a major risk factor
for colon cancer, was higher in Casp12/ tumors compared to
all other groups (Figure S4C). The microarray results provided an
interesting gene signature associated with colitis-promoted
CRC and corroborated the findings that Casp12/ mice ex-
hibited an increased inflammatory response after injury, a prereq-
uisite to compensatory proliferation and cell survival, and
such a response eventually leads to enhanced intestinal
tumorigenesis.
DISCUSSION
A normal inflammatory reaction is self limiting because of various
negative regulatory mechanisms induced to end the response
(Coussens and Werb, 2002). These include anti-inflammatory
cytokines and negative regulators of innate immunity and cyto-
kine receptor pathways. When these molecular ‘‘brakes’’ are
compromised, chronic inflammation ensues. The essential role
of TLRs and NF-kB signaling in promoting tumorigenesis was
highlighted by studies assessing onset of spontaneous CRC as
well as colitis-associated CRC in targeted-gene deletion mouse
models. These studies showed that deletion of MyD88 (Rakoff-
Nahoum and Medzhitov, 2007) or IKKb (Clevers, 2004) markedly
reduced the incidence of tumor formation. In contrast, deletion of
negative regulators of inflammation such as that of the Suppres-
sors Of Cytokine Signaling, SOCS1 (Hanada et al., 2006) or
SOCS3 (Rigby et al., 2007), or of the dominant negative modu-
lator of TLR-IL-1 receptor signaling SIGIRR (Xiao et al., 2007)
resulted in higher tumor incidence. Here, we present results
that show that deletion of caspase-12 resulted in higher tumor
incidence. Our results indicate an essential contribution of the
inflammasome-caspase-1-caspase-12 pathway in maintenance
of intestinal homeostasis: a unique role for caspase-1 in tissue
repair after injury and the control of the inflammatory response
by caspase-12 contributes to immune tolerance in the gut.
Our results are in disagreement with a previous report showing
resistance of caspase-1-deficient mice to acute and chronic
colitis (Siegmund et al., 2001). This discrepancy may be attribut-
able to differences in genetic background, gender of the animals
used, and the microflora environment of the different animal
facilities. The response of Casp1/ mice to DSS in our experi-
ments is highly similar to that of Il18/, Il18r1/. and
Myd88/ mice indicating one of two non-mutually exclusive
possibilities: (1) that IL-18 is cytoprotective and that its signaling
through MyD88 is critical to induce a tissue repair response after
injury and (2) that TLRs and NLRs cooperate in inducing the
signal to repair. Our results showing that exogenous administra-376 Immunity 32, 367–378, March 26, 2010 ª2010 Elsevier Inc.tion of IL-18 rescued Casp1/ mice from acute DSS injury are
consistent with these two possibilities. The role of TLRs in tissue
repair is linked to their ability to sense commensal bacteria in the
colon. The cytosolic localization of NLRs renders them less
accessible to commensal bacteria at the steady state. However,
in response to a mechanical or chemical injury, invading com-
mensals or bacterial products could reach the cytosol of both
epithelial and myeloid cells. Furthermore, danger signals gener-
ated by tissue damage, such as excess ATP, are also known to
stimulate NLRs and activate caspase-1.
Caspase-1 is activated within the inflammasome, and the
best-characterized inflammasomes to date, namely NLRP1,
NLRP3, IPAF, and NAIP5 inflammasomes, utilize the adaptor
ASC to recruit and activate caspase-1 (Mariathasan and Mon-
ack, 2007). In addition to the role of ASC in the activation
of the inflammasome, ASC has been reported to modulate
NF-kB signaling in response to proinflammatory stimuli including
TNFa and LPS (Stehlik et al., 2002). Asc/ mice had a milder
phenotype compared to Casp1/ mice, which could be due
to derepression of the NF-kB pathway.
Our results show thatCasp12/ mice were highly susceptible
to sustained DSS treatment. This result is similar to what was
observed in ATG16L1 null mice, in which the inflammasome
was derepressed, as well as mice deficient in the dominant-
negative modulator of TLR-IL-1 receptor signaling SIGIRR
(Xiao et al., 2007), indicating that tight control of the caspase-
1-IL-1R axis of inflammation is key to achieve immune tolerance
in the gut and that deregulation of this pathway contributes to
pathogenesis of inflammatory bowel diseases (IBDs).
Inflammatory bowel diseases, including ulcerative colitis and
Crohn’s disease, are associated with an elevated risk of CRC
(Clevers, 2004), and here we showed that deregulation of the
inflammatory caspase pathway underlies inflammation-associ-
ated tumorigenesis. C57Bl/6 mice are relatively resistant to
tumorigenesis induced by the AOM+DSS regimen, developing
five to six small adenomas at the most distal end of the colon.
In sharp contrast,Casp12/mice had a drastic increase in tumor
burden compared to caspase-12-proficient animals. Addition-
ally, their tumors were larger and were distributed throughout
the colon length. Using functional genomics, we established a
molecular signature of inflammation-promoted CRC in the
Casp12/ mice, with evidence that genes involved in inflamma-
tion, immunity, and survival signaling are key to tumorigenesis.
In summary, we report a role of the inflammatory caspases
in the regulation of tissue repair and immune tolerance to
commensal microorganisms and provide a direct link between
inflammatory caspase deregulation, colitis, and colitis-associ-
ated tumorigenesis. These results have important therapeutic
implications for managing inflammatory bowel diseases and
inflammation-associated colorectal cancer.EXPERIMENTAL PROCEDURES
Animal Strains
Caspase-12 (Casp12/)-, caspase-1 (Casp1/)-, and ASC (Asc/)-deficient
mice on a C57Bl/6J background were bred and maintained at the McGill
University Health Center. All animals used were 8–12 weeks old. All experi-
ments were performed under guidelines of the animal ethics committee of
McGill University (Canada).
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Experimental colitis was induced by adding DSS (55,000 kDa, MP Biomedical
Cat# 160110) to the drinking water at a concentration of 3% (w/v). The animals
were weighed daily and monitored for signs of distress as well as rectal
bleeding. The scores for stool consistency were measured as in (Wirtz et al.,
2007): (0) normal, (1) soft but formed, (2) very soft, (3) diarrhea, and (4) dysen-
teric diarrhea. Animals were treated either for 5 days and then allowed to
recover by drinking water for additional 4 days or were treated continuously
with DSS for 15 days. Blood was collected from mice with heart puncture.
For the IL-18 rescue experiments, recombinant IL-18 (R&D, Cat#B002-5)
was injected intraperitoneally at a concentration of 0.05 mg per mouse on
days 0, 1, and 2 post-DSS. For the adoptive transfer experiments, spleeno-
cytes extracted with Lympholyte-M (Cedarlane, Cat#CL5035) were depleted
of T and B cells with anti-CD90.2 (Miltenyi biotech, Cat#130-049-101) and
anti-CD19 (Miltenyi biotech, Cat#130-052-201), respectively, and injected
intravenously at a concentration of 5–6 million cells/100 ml per mouse, on
days 3, 4, and 5 post-DSS.
Isolation of Intestinal Epithelial Cells and Lamina Propria Cells
After dissection, colons were isolated and washed with cold RPMI (Wisent,
Cat#350-000CL) supplemented with penicillin and streptomycin (Invitrogen,
Cat#15140-122) and gentamycin (Invitrogen, Cat#15710-064). Colons were
then cut into small pieces and incubated in RPMI containing antibiotics,
5 mM EDTA (Sigma, Cat#E5134), 3% FBS (Wisent, Cat#095-150), and
0.145 mg/ml DTT (Sigma, Cat#43817) for 30 min at 37C with gentle shaking.
For isolation of IECs, the supernatant was filtered in 100 mM strainers (Fisher,
Cat#08-771-19) and centrifuged, and cells were resuspended in 30% (vol/vol)
Percoll (Sigma, Cat#P4937). After centrifugation, the top layer was isolated,
100,000 cells were plated on collagen type I (VWR, Cat#CACB354236)-coated
96-well plates and cultured overnight. For the isolation of lamina propria cells,
the remaining colon pieces were recovered and incubated in RPMI containing
antibiotics, 0.1 mg/ml liberase TL (Roche, Cat#05401020001), and 0.05%
DNase (Roche, Cat#10104159001) for 30 min at 37C with gentle shaking.
Supernatant was filtered with 70 mM strainers (Fisher, Cat#08-771-2). Dendritic
cells and macrophages were then sorted with Pan DC (Miltenyi Biotec,
Cat#130-092-465) and anti-CD11b (Miltenyi Biotec, Cat#130-049-601) mi-
crobeads, respectively. Cells were then cultured overnight in 96-well
plates. The remainder of the lamina propria cells (consisting mostly of lympho-
cytes), labeled ‘‘others,’’ were also cultured along with the IECs, macrophages,
and DCs.
Induction of Tumorigenesis
Colitis-associated CRC was induced by injection of mice intraperitoneally,
on day 0, with azoxymethane AOM (Sigma Cat#A2853) at a concentration of
12.5 mg/kg. On day 7, DSS was introduced in the drinking water at a concen-
tration of 3% for 1 week, and 2 weeks of regular drinking water followed. The
DSS treatment was repeated for two additional cycles but at a concentration of
2%. Mice were sacrificed on week 17; colons were removed from animals,
flushed with cold PBS, and cut longitudinally. A picture of the colon was taken
with a PowerShot G3 Digital Camera (Canon). The tumor size was measured
with a caliper.
Quantitative Real-Time PCR
Two micrograms of total RNA was reverse transcribed with M-MLV reverse
transcriptase (Invitrogen, Cat#28025-013) and random hexamers in a volume
of 20 ml according to the manufacturer’s protocol. The primers used for
quantitative real-time PCR are listed in the Supplemental Information.
ELISA
Serum collected from mice and primary cell culture supernatants were exam-
ined for IL-18 and SAA concentrations with kits from R&D and Invitrogen,
respectively.
Assessment of Intestinal Permeability
Intestinal macromolecular permeability was determined in mice by adminis-
tering 400 mg fluorescein isothiocyanate (FITC)-dextran/g body weight as
detailed in the Supplemental Information.Histopathology and Immunohistochemistry
A histopathologist blindly assessed the level of colitis. The scoring system was
as follows: (1) 1%–25%, (2) 26%–50%, (3) 51%–75%, and (4) 76%–100%
based on the percentage of tissue affected by inflammation or crypt damage.
Immunohistochemistry was performed on paraffin sections as detailed in the
Supplemental Information.
Fluorescence In Situ Hybridization
Formalin-fixed paraffin-embedded sections were deparaffinized and rehy-
drated. Sections were incubated overnight at 37C in the dark with Texas
red-conjugated EUB338 general bacterial probe (50-GCT GCC TCC CGT
AGG AGT-30) (Amann et al., 1990; Lupp et al., 2007) diluted to a final concen-
tration of 2.5 ng/mL in hybridization solution (0.9 M NaCl, 0.1 M Tris [pH 7.2],
30% formamide, and 0.1% SDS). Sections were then washed once in the
dark with hybridization solution for 15 min with gentle shaking. This step was
repeated once with wash buffer (0.9 M NaCL, 0.1 M Tris [pH 7.2]), and sections
were placed in dH2O, mounted with ProLong Gold Antifade (Molecular Probes)
that contains DAPI, and imaged as described above.
DNA Microarray
Total RNA was prepared from tissues and purified an RNeasy Mini kit
(QIAGEN, Cat#74104) in accordance with the manufacturer’s instructions.
RNA quality was ensured with the Agilent Systems Bioanalyzer. Biotinylated
RNA was prepared with an Illumina TotalPrep RNA amplification kit (Ambion,
Cat#AMIL1791) and hybridized to Illumina Mouse Ref-8 Expression Bead-
Chips. Mouse Ref-8 Expression BeadChip contains 24,000 well-annotated
RefSeq transcripts. The McGill University and Ge´nome Que´bec Innovation
Centre performed RNA labeling, amplification, array hybridization, and scan-
ning. Data obtained were analyzed with GeneSifter (Geospiza) and Cluster
3.0 (http://rana.lbl.gov).
Statistical Analysis
Data is represented as average ± standard error. Two-tailed Student’s t test
and ANOVA were used for evaluating statistical significance between groups.
Kaplan-Meier was used for survival analyses.ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE20407.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at
doi:10.1016/j.immuni.2010.02.012.
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